Literature DB >> 30975617

Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.

Saeed A Bohlega1, Hussam Abou-Al-Shaar2, Amaal AlDakheel3, Huda Alajlan4, Balsam S Bohlega3, Brian F Meyer4, Dorota Monies4, Edward J Cupler5, Amr M Al-Saif6.   

Abstract

INTRODUCTION: ADCY5-related hyperkinesia encompasses a heterogeneous group of phenotypes, including paroxysmal chorea, myoclonus, and dystonia. The disease is attributed to mutations of ADCY5, which encodes an adenylate cyclase enzyme. The disease can occur in a sporadic or familial pattern. With exception of one study, all reports on familial ADCY5-related hyperkinesia were associated with an autosomal dominant inheritance. Herein, we describe a native Arabian Bedouin family with an autosomal recessive ADCY5-related disorder and expand the genotypic and phenotypic spectrum of this disorder.
METHODS: The pedigree included 4 generations of a family with 6 affected individuals. The patients were examined clinically and radiologically. Homozygosity mapping and Whole Exome Sequencing (WES) were used to identify a variant, predicted to be pathogenic, which segregated with disease in this family.
RESULTS: All patients presented with early-onset dystonia and myoclonus. The patients had delayed motor and language milestones, axial hypotonia, severe anxiety, social phobia, and isolation. One patient had dilated cardiomyopathy. WES of one affected individual revealed a novel homozygous missense mutation (c.1762G > A, p.D588N) of ADCY5, that segregated with disease in an autosomal recessive manner, and was absent in more than 1000 ethnically-matched chromosomes. The mutation replaces a highly conserved nucleotide and is predicted to be deleterious.
CONCLUSION: This study reports the second family with autosomal recessive childhood-onset ADCY5-related disorder and expands our understanding of phenotype/genotype correlations of this disorder.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  ADCY5; Adenylyl cyclase 5; Autosomal recessive; Dystonia; Genotype; Mutation; Myoclonus; Phenotype

Mesh:

Substances:

Year:  2019        PMID: 30975617     DOI: 10.1016/j.parkreldis.2019.02.039

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  11 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

2.  ADCY5 Related Dyskinesia-A Rare Mutation.

Authors:  Bandari Mahesh; Varun Kumar Singh; Abhishek Pathak; Anand Kumar; Rameshwar Nath Chaurasia
Journal:  Mov Disord Clin Pract       Date:  2022-02-16

Review 3.  ADCY5-Related Dyskinesia: Improving Clinical Detection of an Evolving Disorder.

Authors:  Nirosen Vijiaratnam; Kailash P Bhatia; Anthony E Lang; Wendy H Raskind; Alberto J Espay
Journal:  Mov Disord Clin Pract       Date:  2019-08-19

4.  Homozygous ADCY5 mutation causes early-onset movement disorder with severe intellectual disability.

Authors:  Nobuhiko Okamoto; Fuyuki Miya; Yukihiro Kitai; Tatsuhiko Tsunoda; Mitsuhiro Kato; Shinji Saitoh; Yonehiro Kanemura; Kenjiro Kosaki
Journal:  Neurol Sci       Date:  2021-03-11       Impact factor: 3.307

5.  The GRIA3 c.2477G > A Variant Causes an Exaggerated Startle Reflex, Chorea, and Multifocal Myoclonus.

Authors:  Juliette Piard; Matthieu Béreau; Wenshu XiangWei; Thomas Wirth; Daniel Amsallem; Lauren Buisson; Philippe Richard; Nana Liu; Yuchen Xu; Scott J Myers; Stephen F Traynelis; Jameleddine Chelly; Mathieu Anheim; Martine Raynaud; Lionel Van Maldergem; Hongjie Yuan
Journal:  Mov Disord       Date:  2020-05-05       Impact factor: 9.698

Review 6.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 7.  Challenges in Clinicogenetic Correlations: One Phenotype - Many Genes.

Authors:  Rahul Gannamani; Sterre van der Veen; Martje van Egmond; Tom J de Koning; Marina A J Tijssen
Journal:  Mov Disord Clin Pract       Date:  2021-03-02

8.  A Novel Homozygous ADCY5 Variant is Associated with a Neurodevelopmental Disorder and Movement Abnormalities.

Authors:  Rauan Kaiyrzhanov; Maha S Zaki; Reza Maroofian; Natalia Dominik; Aboulfazl Rad; Barbara Vona; Henry Houlden
Journal:  Mov Disord Clin Pract       Date:  2021-07-31

9.  Hyperphosphorylated Tau, Increased Adenylate Cyclase 5 (ADCY5) Immunoreactivity, but No Neuronal Loss in ADCY5-Dyskinesia.

Authors:  Dong-Hui Chen; Caitlin S Latimer; Min Spencer; Prasanthi Karna; Luis F Gonzalez-Cuyar; Marie Y Davis; C Dirk Keene; Thomas D Bird; Wendy H Raskind
Journal:  Mov Disord Clin Pract       Date:  2019-12-14

Review 10.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.